September 2022
Dysregulated stem cell niches and altered lymphocyte recirculation cause B and T cell lymphopenia in WHIM syndrome
Source: Sci Immunol.
September 2022
Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants
Source: Genes Immun.
August 2022
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome
Source: Blood
June 2022
Can we identify WHIM in infancy? Opportunities with the public newborn screening process
Source: Am J Med Genet C Semin Med Genet
February 2022
Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature
Source: Skin Health And Disease
January 2020
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome
Source: Curr Opin Hematol.
August 2019
WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure
Source: J Clin Immunol.
May 2019
Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies
Source: J Allergy Clin Immunol Pract.
December 2017
How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome
Source: Blood
September 2012
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry
Source: Orphanet J Rare Dis.
Chronic Neutropenia
July 2022
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
Source: Blood Adv.
January 2022
Congenital neutropenia: disease models guiding new treatment strategies
Source: Current Opinion Hematology
October 2021
Chronic neutropenia: how best to assess severity and approach management?
Source: Expert Rev Hematol.
May 2011
Quality of life and patient-reported outcomes in chronic severe neutropenia conditions
Source: Int J Hematol.